Abstract:Background: To evaluate both the impact of hepatitis B virus (HBV)-DNA copies in women with HBV infection on the ovarian reserve function and outcomes of in vitro fertilization (IVF).Methods: We conducted a retrospective study on a total of 9927 couples undergoing their first IVF cycle. After filtering, 1570 couples (546 HBV-seropositive women and 1024 HBV-seronegative women whose partners were HBV-seronegative) failed to meet inclusion criteria. According to the HBV-DNA titers in serum, the HBV-seropositive group was divided into three groups: DNA-high copy group (n = 139), DNA-low copy group (n = 241), and DNA-negative group (n = 166). All patients underwent controlled ovarian hyperstimulation using the long downregulation protocol followed by IVF. Results: Compared with the HBV-negative group, HBV-positive women with high DNA copy exhibited lower antral follicle count (AFC) (11.9 ± 4.3 vs 13.3± 3.2), lower number of oocyte retrieved (9.2± 5.7 vs 13.1± 6.1), larger proportion of AFC<8 (7.9% vs 3.1%) and anti-mullerian hormone (AMH) <2 μg/L (8.6% vs 4.3%). Both high-DNA copy and low-DNA copy groups exhibited a lower fertilization rate (70.9% and 72.5% vs 75.1%), lower high-grade embryo rate (51.5% and 53.8% vs 56.9%), lower implantation rate (31.3% and 32.7% vs 38.5%), lower clinical pregnancy rate (40.3% and 42.3% vs 49.6% per cycle with OR; 45.5% and 48.8% vs 56.8% per cycle with ET) than the HBV-negative group. Moreover, a higher early abortion rate (19.6% and 15.7% vs 7.1%) was observed in the above two groups. Conclusion: HBV-DNA may have a negative effect on women’s ovarian reserve function which in turn results in poor fertilization rate, clinical pregnancy rate and high early abortion rate in IVF treatment.

Study of HBV-DNA in Ovarian Granulosa Cells of Hepatitis B Carriers

The presence and expression of the hepatitis B virus in human oocytes and embryos

Ovarian HBV replication following ovulation induction in female hepatitis B carriers undergoing IVF treatment: A prospective observational study

Presence of HBsAg, HBcAg, and HBVDNA in ovary and ovum of the patients with chronic hepatitis B virus infection.

Hepatitis B virus infection primary cultured human granulosa cells in vitro

Hepatitis B Virus Infection and Replication in Primary Cultured Human Granulosa Cells

Virus Analog Decreases Estradiol Secretion in FSH-treated Human Ovarian Granulosa Cells

Expression of HBsAg and HBcAg in the Ovaries and Ova of Patients with Chronic Hepatitis B

Hepatitis B Virus in Oocytes and Embryos: Pregnancy Outcomes and Children’s Health

Detection of HBsAg, HBcAg, and HBV DNA in Ovarian Tissues from Patients with HBV Infection

[Relationship Between the Expression of HBV DNA, HBV Cccdna in Human Ovary Tissues and the HBV Intrauterine Infection].

Correlation Between Vertical Transmission of Hepatitis B Virus and the Expression of HBsAg in Ovarian Follicles and Placenta

Analysis of the Factors Correlated to HBV Cccdna in Human Ovarian in Pregnant Women with Hepatitis B E Antigen Positive

Relationship Between HBV Cccdna Expression in the Human Ovary and Vertical Transmission of HBV.

Hepatitis B Virus Expression and Replication in Ovum and the Influencing Factors.

Expression and Location & Clinical Signifieance in Ovarian Tissues from Patients with HBV Infection

Expression of HCVAg in ovary and oviduct of the patients with chronic hepatitis C

Significance and Detection of HBV DNA in Spermatozoa with Hepatitis B Virus Carriers

Explore the Security in HBV Carried Infertility Patients During the In-Vitro-fertilization Procedure

Analyzing the Detrimental Effects of Female Chronic Hepatitis B Virus DNA on Ovarian Reserve Function and Results of in Vitro Fertilization

The study on role of peripheral blood mononuclear cell in HBV intrauterine infection